The miR‐26a/SIRT6/HIF‐1α axis regulates glycolysis and inflammatory responses in host macrophages during Mycobacterium tuberculosis infection

Soumya Mal,Debayan Majumder,Pankaj Birari,Arun Kumar Sharma,Umesh Gupta,Kuladip Jana,Manikuntala Kundu,Joyoti Basu
DOI: https://doi.org/10.1002/1873-3468.15001
2024-08-19
FEBS Letters
Abstract:Mycobacterium tuberculosis (Mtb) infection downregulates miR‐26a, which leads to upregulation of the miR26a target SIRT6, a histone deacetylase. SIRT6 suppresses glycolysis and glucose uptake during Mtb infection. SIRT6 also represses intracellular succinate, which in turn controls stabilization of HIF‐1α and release of IL‐1β. SIRT6 is associated with altering macrophage signaling pathways to reduce the antibacterial immune response. Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis. Here, a macrophage infection model was used to unravel the role of the histone deacetylase sirtuin 6 (SIRT6) in Mtb‐triggered regulation of the innate immune response. Mtb infection downregulated microRNA‐26a and upregulated its target SIRT6. SIRT6 suppressed glycolysis and expression of HIF‐1α‐dependent glycolytic genes during infection. In addition, SIRT6 regulated the levels of intracellular succinate which controls stabilization of HIF‐1α, as well as the release of interleukin (IL)‐1β. Furthermore, SIRT6 inhibited inducible nitric oxide synthase (iNOS) and proinflammatory IL‐6 but augmented anti‐inflammatory arginase expression. The miR‐26a/SIRT6/HIF‐1α axis therefore regulates glycolysis and macrophage immune responses during Mtb infection. Our findings link SIRT6 to rewiring of macrophage signaling pathways facilitating dampening of the antibacterial immune response.
cell biology,biochemistry & molecular biology,biophysics
What problem does this paper attempt to address?